Dietary and health supplements; pharmaceutical preparations for treating oncological and/or autoimmune diseases; pharmaceutical preparations for cancer, for example, treating myeloproliferative neoplasms (MPNs); pharmaceutical preparations for treating polycythemia vera (PV); pharmaceutical preparations for treating essential thrombocythemia (ET); pharmaceutical preparations for treating myelofibrosis (MF); pharmaceutical preparations for treating chronic myelogenous leukemia (CML); pharmaceutical preparations for treating chronic neutrophilic leukemia (CNL). Injector containing pharmaceutical preparations for treating oncological and/or autoimmune diseases; injector containing pharmaceutical preparations for treating oncological and/or autoimmune diseases; injector containing pharmaceutical preparations for oncological treatment, in particular, MPNs